Rosen Alexander Gustaf Erik 4

What Happened
Alexander Gustaf Erik Rosen, Chief Administrative Officer of Jupiter Neurosciences (JUNS), received a grant of 341,843 stock options on 2026-06-02. The reported transaction is an award (derivative instrument) with a reported acquisition price of $0.00 (i.e., no cash paid at grant). This is a compensation award rather than a market purchase or sale.

Key Details

• Transaction date: 2026-06-02; Form 4 filed: 2026-06-04 (within the typical two-business-day window).
• Instrument: 341,843 stock options (derivative award). Reported transaction price: $0.00.
• Footnote: Options were granted under the Issuer’s 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025.
• Vesting: Options vest over three years beginning September 2, 2026, in equal quarterly installments, subject to continued employment through each vesting date.
• Shares/options owned after the transaction: not specified in the provided filing excerpt.
• Filing timeliness: appears timely (no late filing flag in the provided data).

Context
These are option awards (rights to acquire shares if/when exercised) rather than immediate share purchases or sales. The grant does not indicate an immediate market transaction or cash flow; value to the insider depends on future vesting and any exercise/strike price (the exercise/strike price is not disclosed in the provided excerpt). Such grants are common compensation for executives and are typically intended to align long-term incentives with company performance.